Literature DB >> 12796165

Rapid pleurodesis for malignant pleural effusions.

Peter A Spiegler1, Adam N Hurewitz, Maritza L Groth.   

Abstract

STUDY
OBJECTIVE: To determine the feasibility of rapid pleurodesis in patients with malignant pleural effusions in order to reduce hospital length of stay in patients with a limited life expectancy.
DESIGN: Prospective case series.
SETTING: Two university hospital programs. PATIENTS: Thirty-eight patients with symptomatic pleural effusions associated with malignancy.
INTERVENTIONS: A 14F catheter was inserted percutaneously into the pleural space after radiographic confirmation of free fluid by lateral decubitus views. Following radiographic confirmation of complete fluid evacuation, a sclerosing agent (ie, talc slurry or bleomycin) was instilled into the pleural space. This was accomplished within 2 h of chest tube insertion, unless the tube was inserted in the evening or if the lung was trapped. After clamping the tube for 90 min, the pleural space was drained for 2 h, after which the chest tube was removed. The intervention was scored as "successful" if no radiographic evidence of fluid reaccumulation was noted at 4 weeks. A "partial successful" score indicated reaccumulation of fluid that did not produce symptoms and did not require repeat pleural drainage of any sort. All other outcomes were scored as "unsuccessful." MEASUREMENTS AND
RESULTS: Forty chest tubes were inserted into 38 patients. Four procedures revealed the presence of a trapped lung and did not result in any attempt at pleurodesis. Five patients who received pleurodesis died in less than 1 month and therefore were not evaluable. Two patients had technical problems with the chest tube and were not evaluable. Of the remaining 29 procedures, drainage procedures with pleurodesis were performed in 27 patients, a complete response was seen in 14 patients (48%), a partial response was seen in 9 patients (31%), and 6 patients (21%) did not respond to pleurodesis. Chemical pleurodesis was completed as an outpatient procedure in only two patients. In one of these, the outcome was unsuccessful. In the remainder, insertion of the chest tube in the evening or additional medical problems necessitated hospital admission, but the entire procedure was completed within 24 h.
CONCLUSIONS: Chemical pleurodesis can be accomplished with good results in < 24 h in the majority of patients with malignant pleural effusions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12796165     DOI: 10.1378/chest.123.6.1895

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Rapid pleurodesis is an outpatient alternative in patients with malignant pleural effusions: a prospective randomized controlled trial.

Authors:  Serkan Özkul; Akif Turna; Ahmet Demirkaya; Burcu Aksoy; Kamil Kaynak
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

2.  Patient evaluation for rapid pleurodesis of malignant pleural effusions.

Authors:  Rebecca Krochmal; Chakravarthy Reddy; Lonny Yarmus; Neeraj R Desai; David Feller-Kopman; Hans J Lee
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

3.  Rapid pleurodesis with doxycycline through a small-bore catheter for the treatment of metastatic malignant effusions.

Authors:  José Manuel Porcel; Antonieta Salud; Maria Nabal; Manuel Vives; Aureli Esquerda; Francisco Rodríguez-Panadero
Journal:  Support Care Cancer       Date:  2006-01-10       Impact factor: 3.603

4.  Successful use of central venous catheters in the management of recurrent malignant pleural effusions: one new option.

Authors:  Abbas Yazdanbod; Azita Salehifar; Nasrollah Maleki; Shahram Habibzadeh; Zahra Tavosi
Journal:  Support Care Cancer       Date:  2015-01-10       Impact factor: 3.603

Review 5.  Management of malignant pleural effusion.

Authors:  Jack A Kastelik
Journal:  Lung       Date:  2013-01-13       Impact factor: 2.584

Review 6.  Interventional pulmonologist perspective: treatment of malignant pleural effusion.

Authors:  Andrew J Sweatt; Arthur Sung
Journal:  Curr Treat Options Oncol       Date:  2014-12

7.  Effect of chest tube size on pleurodesis efficacy in malignant pleural effusion: a meta-analysis of randomized controlled trials.

Authors:  Inderpal Thethi; Shokufeh Ramirez; Wei Shen; Dingding Zhang; Maha Mohamad; Upendra Kaphle; Fayez Kheir
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

8.  Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis.

Authors:  Huan Xia; Xiao-Juan Wang; Qiong Zhou; Huan-Zhong Shi; Zhao-Hui Tong
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

9.  Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma.

Authors:  Akash Verma; Akhil Chopra; Yeo W Lee; Lavina D Bharwani; Atasha B Asmat; Dokeu B A Aneez; Fazuludeen A Akbar; Albert Y H Lim; Sanjay H Chotirmall; John Abisheganaden
Journal:  Curr Drug Discov Technol       Date:  2016

10.  Experience with Ambulatory Management of Pleural Pathologies Utilizing Small-Bore Indwelling Pleural Catheters.

Authors:  Imad-Ud-Din Saqib; Mobeen Iqbal; Atif Rana; Saira Hassan
Journal:  Cureus       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.